Key facts

Active Substance
  • lopinavir
  • lamivudine
  • ritonavir
  • zidovudine
Therapeutic area
Infectious diseases
Decision number
P/0175/2013
PIP number
EMEA-001368-PIP01-12
Pharmaceutical form(s)
Film-coated tablet
Condition(s) / indication(s)
Treatment of human immunodeficiency virus (HIV-1) infection
Route(s) of administration
Oral use
Contact for public enquiries

AbbVie Ltd

United Kingdom
paediatricteam@abbvie.com
Tel: +441628644475
Fax: +44 1628672551

Decision type
W: decision granting a waiver in all age groups for all conditions or indications
Decision date

Decision

How useful do you find this page?